Published in the European Journal of Pain, a study of 4390 Danish twins aged over 70 years old has found that those suffering from back pain had a 13% increased risk of all-cause mortality. The study investigated whether spinal pain increased the rate of all-cause and disease-specific cardiovascular mortality.
Pelvic parameters are a “very hot topic” in spine, according to Howard Place, (St Louis, USA), lead author of a “Best Paper”-winning study on pelvic incidence, presented at the Annual Meeting of the North American Spine Society (NASS, 26-29 October; Boston, USA). Classification systems for conditions such as adult spinal deformity and spondylolisthesis increasingly use pelvic parameters as part of their calculations. Place and colleagues sought to investigate the reliability of accepting pelvic incidence as a “fixed” value by assessing its variability among healthy volunteers with no history of spinal abnormality. The team observed pelvic incidence changes in more than 80% of their subjects, bringing into question the basic utility of the value.
Paralysis is just one of the many serious health problems faced by patients who suffer spinal cord injuries, according to a report according to a report published on spinal cord injury published in Current Neurology and Neuroscience Reports.
DePuy Synthes, in collaboration with LifeNet Health, has launched ViviGen Formable cellular bone matrix, a second-generation cellular allograft designed to assist in the formation of bone during spinal fusion surgery.
The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication Taskforce. This programme aims to accelerate US patient access to new technologies by gathering evidence of clinical effectiveness in an attempt to encourage US insurers to fund new treatments, post FDA-approval.
Zebra Medical Vision has announced the latest algorithm to be included in its Deep Learning Imaging Analytics platform. The algorithm, capable of detecting vertebral fractures, is the latest addition to a line of automated tools that have been announced over the past year.
The UK’s National Institute for Health and Care Excellence (NICE) has updated its advice on the treatment of low back pain in those over 16, recommending exercise in all forms as the best way to begin management. The guidelines now refer to treatment for sciatica as well as back pain.
The International Society for the Advancement of Spine Surgery (ISASS) has issued a policy statement recommending the coverage of lumbar decompression with interlaminar stabilisation in carefully selected patients.
Junyoung Ahn (Department of Orthopedic Surgery, Rush University Medical Center, Chicago, USA) and others report in The Spine Journal that continued surgical experience in the context of minimally invasive lumbar decompression, with or without discectomy, is associated with reduced operative times and reduced hospital stay, but not improved clinical outcomes. They conclude that a minimally invasive lumbar decompression could, therefore, be performed safely without prior experience.
The Solitaire™ Platinum Revascularization Device is the next generation into the Solitaire™ family which has an enhanced meaningful visibility that provides feedback during placement, deployment and retrieval in the treatment of stroke patients, completing Medtronic’s stroke portfolio with the longest and widest stent retriever available in the market with its new 6x40mm stent.
Enrolment is now complete in the ARISE II clinical trial which is assessing the safety and effectiveness of the EmboTrap II revascularisation device (Neuravi), an advanced stent retriever platform for the treatment of acute ischaemic stroke.
As principal investigator for the REVASCAT and DAWN trials and having leadership roles in the SWIFT PRIME and ESCAPE trials, Tudor Jovin (University of Pittsburgh School of Medicine, Pittsburgh, USA) has been heavily involved in the development of the field of stroke treatment for many years. In this interview with NeuroNews, he discusses the development of his career, the urgent updates that need to be made in the stroke treatment strategy and gives his advice for young interventional neurologists.
As the number of patients eligible for endovascular treatment of acute ischaemic stroke increases, centres across Europe must consider whether there are enough interventionalists to fight the burden of stroke. According to Urs Fischer (University of Bern, Bern, Switzerland), while some countries, like Germany, might have an adequate number of interventionalists capable of providing thrombectomy procedures, the rest of Europe does not.
The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique) and stent retriever as frontline mechanical thrombectomy strategies in the treatment of large vessel occlusion (LVO) stroke.
Endovascular aneurysm therapy today is characterised by a rapidly growing and evolving collection of available treatment devices. The challenge in achieving optimal results lies not only in the manual skill of an individual operator, but certainly also in selecting the best treatment approach for a given patient’s aneurysm.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos